Only clinical (salivary gland enlargement, lymphadenopathy, and Raynaud’s phenomenon) and serological (anti-Ro and anti-La antibodies, RF positivity, MG, and low C4) features resulted as independent adverse predictors for NHL development. The gene discussed is C4A; the disease is myasthenia gravis.